Abdominal Fibromatosis

Subscribe to Selected New Research on Abdominal Fibromatosis

14 relevant articles (0 outcomes, 1 trials/studies) found for this Disease

Description: A relatively large mass of unusually firm scarlike connective tissue resulting from active participation of fibroblasts, occurring most frequently in the abdominal muscles of women who have borne children. The fibroblasts infiltrate surrounding muscle and fascia. (Stedman, 25th ed)

Also Known As:

Fibromatosis, Abdominal; Abdominal Fibromatoses; Fibromatoses, Abdominal

Disease Context: Research Results

Neoplasms: 387640

Neoplasms by Histologic Type: 1

Connective and Soft Tissue Neoplasms

Connective Tissue Neoplasms: 6

Fibrous Tissue Neoplasms

Fibroma: 749

Abdominal Fibromatosis: 14

Related Diseases

1.	Neoplasms (Cancer)
2.	Aggressive Fibromatosis (Desmoid)
3.	Fibrosarcoma
4.	Fibroma (Fibromatosis)
5.	Malignant Fibrous Histiocytoma

Experts

1.	Negri, Tiziana: 1 article (11/2006)
2.	Pilotti, Silvana: 1 article (11/2006)
3.	Pricl, Sabrina: 1 article (11/2006)
4.	Tamborini, Elena: 1 article (11/2006)
5.	Lagonigro, M Stefania: 1 article (11/2006)
6.	Miselli, Francesca: 1 article (11/2006)
7.	Di Stefano, Donatella: 1 article (04/2006)
8.	Noguchi, Tetsuro: 1 article (04/2006)
9.	Bertucci, Francois: 1 article (04/2006)
10.	Jacquemier, Jocelyne: 1 article (04/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Abdominal Fibromatosis:

1.	Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link 07/01/1995 - "Role of technetium-99m pertechnetate scintigraphy in the management of extra-abdominal fibromatosis." 07/01/1995 - "The purpose of this study was to investigate technetium-99m pertechnetate (Tc-99m) as a tumor-scanning agent in patients with extra-abdominal fibromatosis, and to establish the sensitivity of this type of scintigraphy" Order ALL the reference details at left...
2.	DNA (Deoxyribonucleic Acid)IBA 09/01/1996 - "DNA flow cytometry was performed on both DFs, three cases of abdominal fibromatosis, and three cases of extraabdominal fibromatosis" 07/01/1994 - "We analyzed the proliferative activities, immunoreactivity of the p53 protein, and aneuploidy in patients with benign and malignant fibrous lesions, including 19 with nodular fasciitis (cellular type) (6-88 years old, mean 42.9), 11 with abdominal fibromatoses (22-74 years old, mean 37.9), 13 with extraabdominal fibromatoses (2-38 years old, mean 19.5), and 23 with fibrosarcomas (adult type: 16-71 years old, mean 47.3; infantile type: 3 months to 9 years, mean 2.9) using immunohistochemistry to determine proliferating cell nuclear antigen (PC10) and p53 protein (CM1) as well as performing DNA flow cytometry" Order ALL the reference details at left...
3.	imatinib (Gleevec)FDA Link 11/01/2006 - "Re: Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis." 04/19/2006 - "Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis." Order ALL the reference details at left...
4.	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/01/1994 - "The distribution pattern of the PCNA-positive cells was uneven in each instance of nodular fasciitis, in contrast to the distribution in abdominal fibromatosis, extraabdominal fibromatosis, and fibrosarcoma" 07/01/1994 - "We analyzed the proliferative activities, immunoreactivity of the p53 protein, and aneuploidy in patients with benign and malignant fibrous lesions, including 19 with nodular fasciitis (cellular type) (6-88 years old, mean 42.9), 11 with abdominal fibromatoses (22-74 years old, mean 37.9), 13 with extraabdominal fibromatoses (2-38 years old, mean 19.5), and 23 with fibrosarcomas (adult type: 16-71 years old, mean 47.3; infantile type: 3 months to 9 years, mean 2.9) using immunohistochemistry to determine proliferating cell nuclear antigen (PC10) and p53 protein (CM1) as well as performing DNA flow cytometry" Order ALL the reference details at left...
5.	RNA (Ribonucleic Acid)IBA 05/01/2001 - "To clarify this relationship, we used in situ hybridization to localize c-fos m-RNA transcripts in 26 fibrous lesions (eight cases of extra-abdominal fibromatosis and six cases each of fibrous dysplasia, fibrosarcoma, and malignant fibrous histiocytoma of bone) as well as six chondrosarcomas and eight conventional high grade osteosarcomas" Order ALL the reference details at left...
6.	Estradiol (Estrace)FDA LinkGeneric 04/01/1992 - "The patient also was found to have mesenteric fibromatosis (abdominal desmoid tumor) and an elevated serum level of estradiol" Order ALL the reference details at left...
7.	CollagenIBA 05/01/2006 - "Intra-abdominal fibromatosis or desmoid tumors are rare forms of connective tissue cellular dysplasia characterized by proliferation of fibroblasts and abundant collagen" Order ALL the reference details at left...
8.	tebufenozide (Mimic)IBA 07/01/2000 - "Intra-abdominal fibromatosis (IAF) is an uncommon benign neoplasm that usually occurs in the mesentery or retroperitoneum and may, on occasion, mimic a gastrointestinal stromal tumor (GIST)" Order ALL the reference details at left...

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 09/01/2005 - "Aggressive intra-abdominal fibromatosis in children and response to chemotherapy." 01/01/1979 - "Chemotherapy: a successful application in abdominal fibromatosis." Order ALL the reference details at left...
2.	Transplantation (Transplant Recipients) 03/01/2005 - "CONCLUSION: Intestinal allo-, or autotransplantation combined with transplantation of the abdominal wall can be lifesaving for patients suffering from extensive intra-abdominal fibromatosis." 03/01/2005 - "Transplantation for the treatment of intra-abdominal fibromatosis." Order ALL the reference details at left...
3.	Laparotomy 02/17/1989 - "We report on a 58 year-old male patient, in whom abdominal fibromatosis occurred 3 years after laparotomy and irradiation on account of rectal cancer" Order ALL the reference details at left...
4.	Appendectomy 08/01/2004 - "Intra-abdominal fibromatosis after appendectomy as cause for ileus]" Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Abdominal Fibromatosis

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 0 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>